Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
about
Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progressionImmunohistochemistry as an important tool in biomarkers detection and clinical practice.HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma.Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility.High cytoplasmic FOXO1 and pFOXO1 expression in astrocytomas are associated with worse surgical outcome.Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to paclitaxel therapy in ovarian carcinoma.Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancerComparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomasCDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladderpNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancerTamoxifen, 17beta-oestradiol and the calmodulin antagonist J8 inhibit human melanoma cell invasion through fibronectinAnti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models.Phase II study of tivantinib (ARQ 197) in patients with metastatic triple-negative breast cancerNecdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary BladderSPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma.Predictive Value of Molecular Subtyping for Locoregional Recurrence in Early-Stage Breast Cancer with N1 without Postmastectomy Radiotherapy.Quality control in molecular immunohistochemistry.A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomasSteroid hormone receptors and their clinical significance in cancer.Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers.Quantitative measures of estrogen receptor expression in relation to breast cancer-specific mortality risk among white women and black women.DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness.The use of mouse models of breast cancer and quantitative image analysis to evaluate hormone receptor antigenicity after microwave-assisted formalin fixationExpression and Significances of G-Protein-Coupled Receptor Kinase 3 in Hepatocellular Carcinoma.Soluble chemokine (C-X-C motif) ligand 16 (CXCL16) in urine as a novel biomarker candidate to identify high grade and muscle invasive urothelial carcinomas.Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma.Identification of glycerol-3-phosphate dehydrogenase 1 as a tumour suppressor in human breast cancer.Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.Parametric mapping of immunohistochemically stained tissue sections; a method to quantify the colocalization of tumor markers.
P2860
Q28534294-E9485D6A-0DFB-4026-B54D-ACB1D28EA8EEQ33704442-2B74B9DA-A5E4-4DBA-864D-DC2781C060B6Q34520094-606661E9-CBD0-45E1-A1F2-BB1E2AADE271Q34649327-90BD2148-2BBC-4629-9A92-E4F1BF9D7B76Q34853582-5EF1CBD1-BC99-40C5-B12B-7D3D1D5DF4DDQ35139059-553B8322-E152-4137-9187-EEFED9BAA0D2Q35233126-BBB7337C-5422-4EDE-BEEA-BA8314572041Q35653135-CD5D4614-6681-479D-AA3F-3851D86A6EFAQ35682594-9016DEBF-04A9-4CC0-BA44-D2667730D8B3Q35984246-ACE30F54-C51B-4BD7-A2EE-6AC1FEA26A8CQ36057092-9A71F308-D931-4FA2-B3FA-9E98CB059258Q36116458-A6E18A1E-8AF3-4F54-A51B-4EAB74F4F1E7Q36126224-1F35613C-5B20-40EF-9100-22FA89A24089Q36169304-206E1484-E2A0-4229-8888-37C81263E374Q36563911-6EF7FFC1-110D-4509-B8D1-3DEB65360121Q36567906-A97F45A0-9B2E-4509-B389-4E9F7F2440C7Q36811094-587647C0-F52D-4BC3-8639-B3A70F1AE698Q37056929-22B1B153-07A6-4BA5-8AA0-F72857C70A08Q37224493-56C3683F-A8FF-4FD4-9F50-974070D65DF3Q37267313-84C6B781-F880-484C-B2C1-14A9C5E168C5Q37268503-13BCA089-B205-47B6-9E8D-8624DD4DC04BQ37350042-158C46AD-3DC2-4139-87D7-A217A436D34CQ37690511-046362E7-B9E5-421A-8865-A4D273B81695Q37709413-CE7FC2B0-0EEF-42F9-B6D1-F69CEEDD267BQ37733734-B678AE5D-8B31-4A28-B80B-646C4AC33AF3Q41439820-2F94E087-247A-4A73-A356-433B5881BEA8Q47093667-833A33F2-9CA6-4EC3-A290-46355A6AD7E9Q47099804-36EA5D40-368F-4018-9294-0FAF16D64710Q47127880-8F7C4E67-F4FB-480E-B178-FF945903B9CDQ47547263-E086847D-FE6E-4996-97D7-19F17974E342Q49921821-C59A88A5-42D2-460C-965F-4440A800FF3BQ55442510-B85D7C18-373C-4180-B0D8-9BCF8E9EF41E
P2860
Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Automated quantitation of immu ...... eptors in human breast cancer.
@en
type
label
Automated quantitation of immu ...... eptors in human breast cancer.
@en
prefLabel
Automated quantitation of immu ...... eptors in human breast cancer.
@en
P2093
P1433
P1476
Automated quantitation of immu ...... ceptors in human breast cancer
@en
P2093
McClelland RA
Nicholson D
Nicholson RI
Robertson JF
P304
P407
P577
1990-06-01T00:00:00Z